Ken Fisher's position in Dexcom is currently worth $137 Million. That's 0.07% of their equity portfolio (149th largest holding). The first Dexcom trade was made in Q2 2020. Since then Ken Fisher bought shares seven more times and sold shares on seven occasions. The stake costed the investor $90.4 Million, netting the investor a gain of 51% so far.